LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
YHGJ
Yunhong Green CTI Ltd.
There isn't enough reported data to score YHGJ yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
YHGJ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Weak |
YHGJ's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
YHGJ PE Valuation
YHGJ has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
YHGJ Forward outlook
There aren't enough analyst estimates for YHGJ to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus YHGJ down 259%.
YHGJ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.60 | $0.00 |
| Q4 2024 | -$0.70 | -$0.60 |
| Q4 2020 | -$18.60 | +$3.90 |
| Q3 2020 | -$20.90 | +$1.90 |
YHGJ is still losing money, but far less than before: $1.11 per share over the past year, against $23.90 at its worst in mid-2020.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over YHGJ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
YHGJ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.9M | -29% |
| Q1 2026 | $6.2M | +28% |
| Q4 2025 | $6.5M | +5.3% |
| Q3 2025 | $3M | +16% |
| Q2 2025 | $5.5M | +25% |
| Q1 2025 | $4.8M | -1.9% |
| Q4 2024 | $6.2M | -8.9% |
| Q3 2024 | $2.5M | +32% |
YHGJ's revenue fell from its 2019 peak and has held roughly level since: $4M last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.2% | -8.6 points |
| Q1 2026 | -1.6% | +2.1 points |
| Q4 2025 | -14% | -29 points |
| Q3 2025 | -33% | +5.7 points |
| Q2 2025 | 0.3% | +4.3 points |
| Q1 2025 | -3.7% | +3.5 points |
| Q4 2024 | 15% | +4.2 points |
| Q3 2024 | -39% | +4.1 points |
YHGJ has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
YHGJ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.3M | +218% |
| Q1 2026 | $209K | -78% |
| Q4 2025 | -$2.5M | -$307K |
| Q3 2025 | $560K | -23% |
| Q2 2025 | $722K | -4.4% |
| Q1 2025 | $950K | +$1.9M |
| Q4 2024 | -$2.2M | -$1.4M |
| Q3 2024 | $726K | -17% |
YHGJ has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
YHGJ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +8.1K shares |
| 1 year | 0% | +556 shares |
| 3 years | +30% | +605K shares |
| 5 years | +432% | +2.1M shares |
| Available history | +580% | +2.2M shares |
YHGJ has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
YHGJ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 11.3x | High |
| Q2 2025 | 15.8x | High |
| Q1 2025 | 678.6x | High |
YHGJ's net debt is about 11 years of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
YHGJ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 68.0 | Neutral |
YHGJ's weekly RSI is 54 (neutral) and its Stochastic is 68 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
YHGJ PE vs Consumer Cyclical Sector
YHGJ has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
YHGJ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.91 | 15% above |
| 20 week MA | $2.94 | 14% above |
| 50 week MA | $3.21 | 4.4% above |
| 100 week MA | $5.14 | 35% below |
| 200 week MA | $10.5 | 68% below |
YHGJ has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
YHGJ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.40 | $19.1 | +158% |
| 2021 | $19.1 | $12.6 | -34% |
| 2022 | $12.6 | $10.5 | -17% |
| 2023 | $10.5 | $21.4 | +104% |
| 2024 | $21.4 | $5.10 | -76% |
| 2025 | $5.10 | $3.78 | -26% |
| 2026 YTD | $3.78 | $3.35 | -11% |
YHGJ has the edge over LCID on returns for 2026, with the stronger performance.